20Med Therapeutics Alternatives & Competitors

12 companies similar to 20Med Therapeutics — Innovative polymer nanoparticle technology for the development of RNA and DNA ba...

Sapreme Therapeutics BV

Next-generation RNA therapeutics through engineered endosomal escape

16 Series A $15.00M

Utrecht, The Netherlands

Biotechnology Life Sciences +1

Orna Therapeutics

Wholly Owned Subsidiary of Eli Lilly and Company

127 Corporate $2.72B

Watertown, United States

Biotechnology Health and Wellness +1

Cardior Pharmaceuticals

Cardior develops RNA-based therapeutics designed to prevent, repair and reverse diseases o...

12 Acquired $1.12B

Germany

Biopharma Biotechnology +1

NanoCarrier Ltd.

14 Post-IPO Debt $8.28B

Biotechnology Pharmaceutical

Rival Readout

Competing with 20Med Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Bound Therapeutics

Safe and effective next generation RNA therapeutics

Cherry Hill, United State...

Biopharma Biotechnology +2

Aera Therapeutics

Enabling the next generation of transformative genetic medicines

91 Series B $58.00M

Cambridge, United States

Biotechnology Pharmaceutical

ARTHEx Biotech

Developing microRNA modulators for diseases with unmet medical needs

28 Series B $62.95M

Paterna, Spain

Biotechnology

NanoVation Therapeutics™

Delivering tomorrow's genetic medicines, today™

42 Grant $300.00K

Canada

Biotechnology Health and Wellness

CAMP4 Therapeutics

Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore heal...

61 $290.00M

Cambridge, United States

Biopharma Biotechnology +1

Nanite

Deliver the Undeliverable

22 Grant $9.80M

Boston, United States

AI Biotechnology +1

PepGen

Better Technology. Better Delivery. Developing a new generation of disease-modifying thera...

64 IPO $465.80M

Boston, United States

Biotechnology

BreezeBio

Genetic Medicine Delivered

65 Series A $67.73M

Brisbane, United States

Biotechnology Health and Wellness +1

About 20Med Therapeutics

20Med Therapeutics is a biotechnology startup founded in 2011 and based in The Netherlands. The company is focused on developing innovative polymer nanoparticle technology for the efficient intracellular delivery of RNA and DNA-based therapeutics and vaccines. Its proprietary nanoparticles are designed with smart funct...

Business keywords

RNA Therapeutics, DNA Therapeutics, Polymer Nanoparticle Technology, Drug Delivery Technology, Biomedical, Nanogels, SiRNA Delivery, MicroRNA Delivery, Intracellular Delivery, Targeted Delivery, Oligonucleotide Delivery, Genetic Disease Treatment, Biodegradable Nanoparticles, Endosomal Escape, Molecular Architecture

Frequently Asked Questions

Companies similar to 20Med Therapeutics include Sapreme Therapeutics BV, Orna Therapeutics, Cardior Pharmaceuticals, NanoCarrier Ltd., Bound Therapeutics. They work in Biotechnology and share 20Med Therapeutics's focus on rna therapeutics, endosomal escape and sirna delivery.

Bounce Watch lists 12 companies that share 20Med Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around 20Med Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

20Med Therapeutics Profile Sapreme Therapeutics BV Alternatives Orna Therapeutics Alternatives Cardior Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at 20Med Therapeutics on 15 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.